Abstract-We designed an association (retrospective, case control) study aimed at evaluating associations between genetic variations of the human apolipoprotein B (apoB) gene and clinical diagnosis of essential hypertension. Our approach was to compare the distribution of the alleles of a highly polymorphic variable number of tandem repeats localized 3Ј to the human apoB gene, the apoB 3Ј hypervariable region (HVR), in a group of normotensive and a group of hypertensive individuals. We collected DNA samples from 437 unrelated nationals (215 normotensives and 222 hypertensives) from the United Arab Emirates (UAEs), and we determined their apoB 3Ј HVR allele and genotype status with a polymerase chain reaction-based assay. In the UAE population, we found 18 alleles underlying a total of 51 genotypes. T he aim of molecular geneticists with respect to the field of hypertension is to identify the part played by genetic factors in the onset of the disorder. The first step is to uncover quantitative trait loci (QTLs) whose products are implicated in abnormal determination of blood pressure. 1-3 Among the many candidate genes suspected to be involved in human essential hypertension, the apolipoprotein B (apoB) gene is of particular interest because of its demonstrated association with cardiovascular diseases (CVDs). 4 A highly polymorphic genetic marker has been described 73 bp 3Ј to the second polyadenylation signal of the human apoB gene, which is located on chromosome 2 and is commonly referred to as apoB 3Ј HVR (hypervariable region). 5, 6 Several alleles of this polymorphic system have been found to be associated with coronary heart disease (CHD) and myocardial infarction as well as with various hyperlipidemia in different populations. 4, [7] [8] [9] A number of clinical entities, such as hypercholesterolemia, hypertension, insulin-resistance syndromes, and obesity, participate in an intricate interaction in the development of atherosclerosis and CVDs. Common genetic susceptibilities probably underlie the phenotypic expression of these classic risk factors. Therefore, candidate genes for a specific clinical entity involved in CVDs, such as atherosclerotic heart disease, are also good candidates for unraveling the molecular architecture of another implicating clinical phenotype, such as hypertension. Yet, to our knowledge, despite the key role played by apoB in the molecular etiology of CVDs, only 1 molecular genetic study has attempted to observe putative correlations of apoB genetic markers and essential hypertension, and it failed to uncover an association between apoB 3Ј HVR and primary hypertension in a Japanese population. 10 Genetic drift and admixture are usually confounding factors in the unraveling of the genetic architecture of complex (multifactorial) traits. On the basis of this reason and also to minimize the problems that underlie investigations based on the concept of linkage disequilibrium, it is of utmost importance to investigate genetically homogeneous ethnic groups. [11] [12] [13] We report here the results of an association (retrospective, case control) study aimed at evaluating the relationship of the apo B 3Ј HVR with essential hypertension. This study was performed on nationals from the Abu Dhabi Emirate, a genetically homogeneous ethnic population without a history of smoking or alcohol consumption.
T he aim of molecular geneticists with respect to the field of hypertension is to identify the part played by genetic factors in the onset of the disorder. The first step is to uncover quantitative trait loci (QTLs) whose products are implicated in abnormal determination of blood pressure. [1] [2] [3] Among the many candidate genes suspected to be involved in human essential hypertension, the apolipoprotein B (apoB) gene is of particular interest because of its demonstrated association with cardiovascular diseases (CVDs). 4 A highly polymorphic genetic marker has been described 73 bp 3Ј to the second polyadenylation signal of the human apoB gene, which is located on chromosome 2 and is commonly referred to as apoB 3Ј HVR (hypervariable region). 5, 6 Several alleles of this polymorphic system have been found to be associated with coronary heart disease (CHD) and myocardial infarction as well as with various hyperlipidemia in different populations. 4, [7] [8] [9] A number of clinical entities, such as hypercholesterolemia, hypertension, insulin-resistance syndromes, and obesity, participate in an intricate interaction in the development of atherosclerosis and CVDs. Common genetic susceptibilities probably underlie the phenotypic expression of these classic risk factors. Therefore, candidate genes for a specific clinical entity involved in CVDs, such as atherosclerotic heart disease, are also good candidates for unraveling the molecular architecture of another implicating clinical phenotype, such as hypertension. Yet, to our knowledge, despite the key role played by apoB in the molecular etiology of CVDs, only 1 molecular genetic study has attempted to observe putative correlations of apoB genetic markers and essential hypertension, and it failed to uncover an association between apoB 3Ј HVR and primary hypertension in a Japanese population. 10 Genetic drift and admixture are usually confounding factors in the unraveling of the genetic architecture of complex (multifactorial) traits. On the basis of this reason and also to minimize the problems that underlie investigations based on the concept of linkage disequilibrium, it is of utmost importance to investigate genetically homogeneous ethnic groups. [11] [12] [13] We report here the results of an association (retrospective, case control) study aimed at evaluating the relationship of the apo B 3Ј HVR with essential hypertension. This study was performed on nationals from the Abu Dhabi Emirate, a genetically homogeneous ethnic population without a history of smoking or alcohol consumption.
Methods

Subjects
The United Arab Emirates (UAEs) is a federation of 7 Emirates, the Abu Dhabi Emirate is the largest, with an indigenous population that comprises UAE nationals, who are Gulf Arabs of Bedouin descent. Until recently, Gulf Bedouin tribes have been characterized by population migrations that have been restricted to this area: intratribal marriages were usual and consanguinity levels were high. The incidence of essential hypertension in the UAEs is similar to that in other parts of the world. 14 Patients were classified as having essential hypertension if they had systolic blood pressures Ͼ140 mm Hg and diastolic blood pressures Ͼ90 mm Hg on at least 3 separate occasions; had no clinical signs, symptoms, and laboratory findings suggestive of secondary hypertension; and had positive family history of hypertension (as assessed by direct questioning of occurrence of hypertension in any close relative). These subjects were all known hypertensive patients who were recruited for this study during ambulatory visits to the hypertension unit for routine checkups. All hypertensive subjects were on antihypertensive medications, and therefore blood pressure values could not be taken into account for this study.
"Control" (comparison) subjects were healthy individuals who had no personal history of hypertension (documented by individual medical records as resting systolic blood pressures Ͻ140 mm Hg and diastolic blood pressures Ͻ90 mm Hg on at least 3 separate occasions) and no family history of hypertension. Control subjects were on neither antihypertensives or any other medication that could affect blood pressure values. Control individuals were taken from a DNA database that we are building from a random population of unrelated UAE nationals (it is currently composed of 3100 DNA samples); they were recruited as normotensive individuals whose age, gender, and BMI matched those of the hypertensive group.
Care was taken to ensure that no subject of this study (whether in hypertensive or normotensive groups) was affected by confounding clinical phenotypes, including non-insulin-dependent diabetes mellitus (that is otherwise quite prevalent in this population) and ischemic heart disease. Moreover, all hypertensive patients had absence of left ventricular hypertrophy as assessed by echocardiography.
DNA Analysis
DNA was extracted from peripheral blood leukocytes isolated from 5-mL blood samples drawn for routine clinical investigations according to standard protocols, and genotypes of the apoB 3Ј HVR were determined by polymerase chain reaction using the method of Boerwinkle et al. 6 Because agarose gel electrophoresis may lead to equivocal assignment of HVR alleles, 15 polymerase chain reaction products were visualized after electrophoretic migration in 4% polyacrylamide gels and staining with ethidium bromide.
On average, the human apoB 3Ј HVR is constituted by tandem repeats of a 30-bp core DNA sequence. 6 The usual nomenclature to describe this polymorphism is to take into account the average number of core, consensus sequences, which are referred to as hypervariable elements (HVE). Thus, a 35-time repeat of the core sequence, for example, is called HVE35, as indicated in the nomenclature of Boerwinkle et al. 6 
Data Analyses
Allele frequencies were determined by the method of gene counting. 16 Statistical determinations were performed with the help of an SPSS version 6.1 for Windows software package (Gorinchem). Differences in the distributions of apoB 3Ј HVR alleles on the basis of clinical phenotypes (normotensive versus hypertensive) were assessed with 2 procedures on corresponding tables of association. Odds ratio (OR) values (95% CI) were determined directly from 2ϫ2 table associations. For all analyses, statistical significance was considered at PϽ0.05.
Results
This study included 437 Emirati subjects (225 men, 212 women) with complete phenotypic and genotypic data. Normotensive "controls" represented a "comparative" rather than a "control" group; they were indeed free of disease up to the time of investigation. They also had no family history of hypertension, which was ascertained by direct questioning and by readouts of individual medical records. They were included in the protocol because their BMIs, age, and gender matched those of the hypertensive patients. Their serum cholesterol levels were significantly lower than those of the hypertensive patients (5.2Ϯ0.5 versus 7.0Ϯ2.7 mmol/L, PϽ0.05). The control subjects, who had neither a personal or family history of essential hypertension, represented a valid comparison group for this association study. BMI values indicate that all subjects were overweight (26ϽBMIϽ30) and that hypertensives were even slightly obese (BMIϾ30). These BMI values are representative of the UAE population, which is an affluent and rapidly expanding society: being overweight is a general characteristic of its members (P.M.F., unpublished data, 1998). Table 1 displays the distribution of the different alleles observed between the 2 groups of 215 normotensive and 222 hypertensive UAE nationals. In the overall population of 437 subjects, we observed the presence of 18 alleles, which ranged from HVE21 to HVE55, and of 51 genotypes (data not shown). In normotensives, the distribution of 13 alleles followed a quadrimodal distribution (Table 1 ) with peaks at HVE31 (respective allele frequency, 15.3%), HVE37 (28.0%), HVE47 (7.7%), and HVE51 (2.8%). In hypertensives, the distribution of 18 alleles gave a trimodal distribution (Table 1 ) with peaks at HVE31 (16.9%), HVE35 (25.7%), and HVE47 (6.1%).
To compare allele frequency distributions in different groups and different populations, a 4-allele model has been proposed, 17 in which apoB 3Ј HVR alleles are registered into 4 classes: HVEϽ35, HVE35, HVE37, and HVEϾ37 (Table  2) . Allele frequency distribution difference between the groups of normotensive and hypertensive subjects was assessed in the 4ϫ2 table of association (Table 2) by a 2 test with 3 df. The test result was 2 ϭ10.11, Pϭ0.017. HVE35 were therefore associated with clinical diagnosis of hypertension (25.7% among hypertensives versus 19.6% in normotensives), whereas HVE37 were associated with normotensive status (28.8% in normotensives versus 20.3% in hypertensives). The OR of the association of HVE35 versus HVE37 with essential hypertension is 1.85 (Cornfield 95% CI for OR are 1.23 to 2.80). Furthermore, HVE36 (0.7%) occurred among only normotensive subjects.
To document differences in the distribution of less common alleles, we designed an a posteriori model in which alleles smaller than HVE35 and larger than HVE37 were pooled to illustrate complete absence of some alleles in the group of normotensives. This model is displayed in Table 3 , and 2 analysis results on the 8ϫ2 table of association were 2 ϭ48.29, 7 df, PϽ1ϫ10
Ϫ8
. Tables 1 and 3 show that HVE21, HVE23, HVE25, HVE49, and HVE55 occurred in the group of hypertensive subjects only (at relative frequencies of 1.4%, 1.4%, 0.7%, 3.4%, and 0.7% respectively), whereas HVE51 were more frequent among normotensive individuals (2.8% versus 0.7%). Statistical differences existed between normotensives and hypertensives in the distribution of all alleles except for HVE27 to HVE33 and HVE39 to HVE47 (Table 3) .
Discussion
It is now well established that association studies at candidate gene loci represent a powerful approach to detect small genetic effects and thus to identify QTLs with reduced or low penetrance; however, these methods are influenced by the effects of population stratification, selection bias, confounding by other variables, and clinical definitions used to characterize patient groups. [11] [12] [13] One way to minimize the weight of the first 2 issues is to probe putative associations between candidate gene variations and a complex, heterogeneous disorder such as primary hypertension in ethnic groups that may be genetically more homogeneous. In such cases, disease-causing mutations are present on 1 or a few ancestral haplotypes and linkage disequilibrium occurs over greater genetic distances than in genetically heterogeneous (or older) populations. The population of UAE subjects that we recruited for this study offered another advantage in that there was no history of smoking or alcohol intake, 2 of the usual confounding environmental factors.
In this study, we demonstrate for the first time a marked, statistically significant association of apoB 3Ј HVR alleles and direct clinical diagnosis of essential hypertension. Several studies have demonstrated correlations between genetic variations of the apoB gene and atherosclerotic CHD and dyslipoproteinemia. 7, 18, 19 Such polymorphisms include apoB 3Ј HVR. From the time that Hegele et al 20 reported an association of the larger apoB 3Ј HVR alleles with myocardial infarction, similar associations with myocardial infarc- tion and with CHD were confirmed in other populations. 8, 21, 22 Another study established an association with the smaller apoB 3Ј HVR. 23 Other research groups have reported negative findings. 24, 25 Despite controversial data in the field of hypertension, there is general agreement that apoB variants that may be in linkage disequilibrium with some apoB 3Ј HVR alleles are directly implicated in dyslipoproteinemia and allied CHD. This working hypothesis has recently been clearly demonstrated by Tybjaerg-Hansen et al, 26 who have shown that mutation Arg3500Gln in the apoB gene causes severe hypercholesterolemia and increases the risk of ischemic heart disease and that this mutation could form the basis for a screening test in the white population in Denmark. More detailed studies aimed at relating apoB gene locus polymorphisms and CVDs should therefore contribute to evidence associations with clinical and intermediate phenotypes that underlie an individual's genetic susceptibility to CVDs.
Clear clinical, epidemiological, and genetic evidence exists that indicates dyslipidemia accompanies essential hypertension and that biological interrelations between blood pressure and blood lipids may influence the mechanisms that associate hypertension and CHD. [27] [28] [29] [30] Thus, studies that focus on unraveling the genetic architecture (based on apoB variants) of coronary artery disease, non-insulin-dependent diabetes mellitus, and hypertension are gaining acceptance. 4, 7, 26 However, in a preliminary investigation on a restricted Japanese population, Higashimori et al 10 reported no association between apoB 3Ј HVR and essential hypertension.
We have shown in a population of UAE nationals that the common allele HVE35 is significantly associated with clinical diagnosis of hypertension: it represents the most frequent allele among hypertensives, in whom its relative frequency is 25.7% (compared with 19.6% in normotensives). HVE37, on the other hand, is the most common allele in normotensives (28.8% versus 20.3% in hypertensives). In other populations that have been studied worldwide, the main peak of apoB 3Ј HVR allelic distribution occurs at either HVE35 or at HVE37, 17 with a marked frequency difference between the two. In Emirati, HVE35 and HVE37 occur with similar frequencies in a random population of subjects (Frossard, unpublished data, 1998) , and a difference becomes apparent when investigating either hypertensive or normotensive subjects. Furthermore, less common individual alleles HVE21, 23, 25, 49, and 55 are present among hypertensives only; taken together, these alleles represent 7.6% of all alleles found in hypertensives (Table 1) . It is interesting to note that "minor" alleles such as HVE25 and HVE60 were also found only in coronary artery disease and stroke patients from Taiwan. 9 Therefore, apoB variants, or variants of any nearby gene, that may be in linkage disequilibrium with HVE21, HVE23, HVE25, HVE35, HVE49, and HVE55 contribute significantly to the development of hypertension in the Emirati population.
Thus, the apoB gene, or any gene that may be in linkage disequilibrium with it, constitutes a good candidate for participation in the determination of an individual's genetic susceptibility to essential hypertension in the indigenous population of the UAE. However, association does not imply causation, and such results should be interpreted with care. 31 Nonetheless, the conclusions reached in this report warrant testing in other populations.
